MysteryVibe, a company known for its clinically-backed sexual health devices, has recently rebranding and announced an expansion of its product offerings broadening its focus to address a wider range of health concerns. The company’s new brand identity, which includes updated branding, messaging, supports plans for future growth. It is designed to reflect its expanded mission and appeal to a broader audience. MysteryVibe’s…
TMRW Life Sciences, the creator of the only FDA-cleared automated specimen management and storage platform for frozen human sperm, eggs, and embryos, has successfully closed a $28+ million Series D equity financing round. This funding aims to meet the increasing demand from fertility clinics for safe and more accurate cryostorage solutions. The financing round was led by 5AM Ventures, with participation from…
Legacy, North America’s leading digital fertility clinic for men, has secured $7.5 million in financing to advance its mission of making male fertility services more accessible. This funding will support the fulfillment of two recently signed contracts to serve over nine million veterans. Legacy, advised by top fertility experts, offers sperm testing and freezing through at-home kits shipped directly to clients. To…
3Daughters, a clinical development company dedicated to advancing women’s healthcare, has announced the successful completion of an oversubscribed seed financing round, raising $4.7 million. This round saw participation from existing investors including Thairm Bio, Argosy Foundation, Wexford Science and Technology, UMass Amherst, and new undisclosed investors. Mary Beth Cicero, CEO of 3Daughters, commented: “We are thrilled by the overwhelming response from both…
French healthtech company Sonio, has introduced Soniopedia, a new cloud-based AI-powered software designed for prenatal ultrasound training. This announcement was made at the World Congress of Fetal Medicine (FMF) in Lisbon. Soniopedia aims to address the training challenges in prenatal ultrasound by simulating cases from the initial ultrasound image to the necessary genetic tests within a single cloud-based platform. Prenatal medicine is…
The European Society of Human Reproduction and Embryology (ESHRE) has launched the Female Reproductive Genetics Initiative (FeRGI), a project aimed at translating genetic research in infertility into clinical practice. Developed within the Special Interest Group (SIG) Reproductive Genetics, FeRGI focuses on providing resources and training to clinicians and biologists to improve the diagnosis and treatment of female infertility. Recent advancements over the…
At the ESHRE Annual Meeting in Amsterdam, data presented revealed that women in Europe are undergoing more cycles of in vitro fertilisation (IVF) and intrauterine insemination (IUI). The data from the ESHRE European IVF Monitoring (EIM) Consortium indicates a steady rise in the use of Assisted Reproductive Technology (ART). In 2021, a total of 1,103,633 ART treatment cycles were reported by 1,382…
It’s 2024. We still don’t know what causes PCOS. We don’t know how to cure it. And we have a limited understanding how to treat it properly. PCOS stands for Polycystic Ovary Syndrome. It’s a syndrome because we don’t really understand it. It’s a syndrome because in medicine ‘syndrome’ refers to a group or collection of symptoms and signs that consistently occur…
